Data-Driven Drug Discovery Webinar

Lessons from R&D Leaders

The promise of developing innovative and lucrative therapeutics and diagnostics in shortened timeframes is accelerating the adoption of data-driven research and development.

However, many organisations are finding it difficult to evolve their established R&D processes and teams to exploit “Data and AI solutions at scale” to improve R&D effectiveness.

During this LIVE webinar, an expert panel of drug discovery leaders from the industry together with Capgemini specialists share their insights on building and leading a high-performance data-driven drug discovery organisation.

The panel will discuss a range of questions including:

  • What are the key trends driving Pharma R&D towards digital transformation?
  • What does a roadmap towards data-driven discovery look like, and how can you avoid or overcome the common pitfalls?
  • How should you set up your organisation to ensure data science projects deliver value?
  • How to structure and manage your discovery data to enable robust, data-driven models to be developed at speed and scale
  • How to measure value and benefits
  • What does a successful data-driven discovery project look like?
  • How can you assess whether a project will deliver value before you commit?
  • How to scale a promising pilot AI project out into a production environment

If you are a researcher, data scientist, technologist or other decision maker looking to deliver value to your drug discovery organisation then join us on the 23rd March for an insightful LIVE discussion and Q&A with our panelists from GSK, Frost & Sullivan and Capgemini – reserve your place now.




Simon Thornber Unmesh Lal Dr James Hinchliffe Emily Tower

Simon Thornber

Product Director Scientific Tools at GSK

Unmesh Lal

Principal, Healthcare & Life Sciences at Frost & Sullivan

James Hinchliffe

Senior Life Sciences R&D Consultant at Capgemini

Emily Tower

Strategy, Life Sciences at Capegmini


Event details

March 23, 2021 3:00 pm
Online Webinar

Discover Altran’s Research